Discover RST Biomed

RST Biomed acts as a single point of contact to address multidisciplinary R&D&i needs, integrating CSIC groups with pharmaceutical and biotechnology companies to streamline the transfer of drugs from the laboratory to clinical trials. In this way, it enables the Groups/ICUs to offer their advanced capabilities to the industry, driving innovation and process optimization.

There are numerous Proofs of Concept (PdC) in the pharmaceutical and biotechnology fields at the development stage, many of which come from SMEs that lack access to advanced techniques and models. CSIC, with its state-of-the-art infrastructure and experts in various disciplines (such as chemistry, biology, physics, and materials science), provides an integrated solution that facilitates technology transfer and collaboration with the industry.

Through RST Biomed, both costs and management times are optimized by providing a comprehensive service, while capabilities and protocols are harmonized, thus improving competitiveness and aligning more closely with the sector’s needs.